Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer. [electronic resource]
Producer: 20081230Description: 1769-74 p. digitalISSN:- 1532-1827
- Antineoplastic Agents, Hormonal -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Blotting, Western
- Breast Neoplasms -- drug therapy
- CSK Tyrosine-Protein Kinase
- Cell Nucleus -- metabolism
- Estrogens -- metabolism
- Female
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Middle Aged
- Neoplasms, Hormone-Dependent -- drug therapy
- Phosphorylation
- Prognosis
- Protein-Tyrosine Kinases -- metabolism
- Proto-Oncogene Proteins -- metabolism
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Tamoxifen -- therapeutic use
- Tissue Array Analysis
- src-Family Kinases
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.